Literature DB >> 10448865

Improved technique for establishing short term human brain tumor cultures.

M A Farr-Jones1, I F Parney, K C Petruk.   

Abstract

Culturing human central nervous system tumors has been difficult compared to other neoplasms. We report improved success rates for establishing short term human brain tumor cultures using a modified tissue processing technique. Eighty-seven brain tumor specimens (56 glioblastomas, 8 mid grade astrocytomas, 8 oligodendrogliomas, 15 other) were obtained from June 1988 to March 1997. The first twenty-three samples were processed by dissection, partial enzyme dissociation, and filtration through a tissue culture sieve. Subsequent samples were processed identically except tumor cells were centrifuged on a density gradient prior to plating. Successful cultures were defined as those surviving greater than three passages in tissue culture and growing to sufficient numbers (>10(6) cells) to allow freezing. Success rate was 42% (10/23) using standard processing methods and 86% (55/64) with the addition of density gradient centrifugation. Glial fibrillary acidic protein (GFAP) and vimentin staining, karyotypes, and growth curves were obtained for representative glioma cultures. All cultures tested were positive for vimentin (29/29) while 62% (18/29) were positive for GFAP. Of four cultures karyotyped (two glioblastomas, two oligodendrogliomas), all but one oligodendroglioma culture exhibited clonal cytogenetic abnormalities. These immunohistochemical and karyotypic results are consistent with the malignant glial origin of these cells. Of note, low passage human glioma cultures grew slower and exhibited more contact inhibition than immortalized human glioblastoma cell lines. Nevertheless, this simple method for establishing short term human brain tumor cultures should aid in further developing human brain tumor pre-clinical models as well as enhancing clinical applications dependent on in vitro human brain tumor cell growth adjust.

Entities:  

Mesh:

Year:  1999        PMID: 10448865     DOI: 10.1023/a:1006115608103

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme.

Authors:  V Bocchini; R Casalone; P Collini; G Rebel; F Lo Curto
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

2.  Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors:  B Westermark; J Pontén; R Hugosson
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-11

3.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines.

Authors:  M Westphal; H Nausch; H D Herrmann
Journal:  J Neurocytol       Date:  1990-08

5.  Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice.

Authors:  S H Bigner; D E Bullard; C N Pegram; C J Wikstrand; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1981-07       Impact factor: 3.685

Review 6.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

7.  A cytogenetic study of 53 human gliomas.

Authors:  R B Jenkins; D W Kimmel; C A Moertel; C G Schultz; B W Scheithauer; P J Kelly; G W Dewald
Journal:  Cancer Genet Cytogenet       Date:  1989-06

8.  Establishment and characterization of two cell lines derived from human glioblastoma multiforme.

Authors:  G Bacciocchi; N Gibelli; C Zibera; P Pedrazzoli; G Bergamaschi; P De Piceis Polver; M Danova; G Mazzini; L Palomba; R Tupler
Journal:  Anticancer Res       Date:  1992 May-Jun       Impact factor: 2.480

9.  Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy.

Authors:  P Y Wen; M A Lampson; L A Lampson
Journal:  J Neuroimmunol       Date:  1992-01       Impact factor: 3.478

10.  Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

Authors:  J Trojan; T R Johnson; S D Rudin; J Ilan; M L Tykocinski; J Ilan
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  7 in total

1.  Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF.

Authors:  A L Gainer; I F Parney; K C Petruk; J F Elliott
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

2.  A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers.

Authors:  Anjali Shiras; Arti Bhosale; Varsha Shepal; Ravi Shukla; V S Baburao; K Prabhakara; Padma Shastry
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

3.  Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy.

Authors:  Anne Clavreul; Isabelle Jean; Laurence Preisser; Agnès Chassevent; Anne Sapin; Sophie Michalak; Philippe Menei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-16       Impact factor: 2.416

4.  Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation.

Authors:  Ian F Parney; James S Waldron; Andrew T Parsa
Journal:  J Neurosurg       Date:  2009-03       Impact factor: 5.115

5.  Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.

Authors:  Ian F Parney; Lung-Ji Chang; Maxine A Farr-Jones; Chunhai Hao; Michael Smylie; Kenneth C Petruk
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.506

6.  Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.

Authors:  Carlos A Fedrigo; Ivana Grivicich; Daniel P Schunemann; Ivan M Chemale; Daiane dos Santos; Thais Jacovas; Patryck S Boschetti; Geraldo P Jotz; Aroldo Braga Filho; Adriana B da Rocha
Journal:  Radiat Oncol       Date:  2011-11-11       Impact factor: 3.481

7.  The Potential of Helianthin Loaded Into Magnetic Nanoparticles to Induce Cytotoxicity in Glioblastoma Cells.

Authors:  Alexandra Costachi; Cătălina Elena Cioc; Sandra Alice Buteică; Daniela Elise Tache; Ştefan-Alexandru Artene; Ani-Simona Sevastre; Oana Alexandru; Ligia Gabriela Tătăranu; Ştefana Oana Popescu; Anica Dricu
Journal:  Curr Health Sci J       Date:  2021-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.